- Concept Companies Leads Development Efforts on Second Phase for Lacerta Therapeutics in Alachua's Progress District
- Fluorescent Immunoassay Market Size, $3.77Bn by 2028, 5.6% CAGR Led by ELISA Segment (56.12% Market Share in 2021): The Insight Partners
- PDS Biotech Announces Presentation of Efficacy and Safety Data from VERSATILE-002 Phase 2 Clinical Trial in Recurrent or Metastatic Head and Neck Cancer at ASCO 2022
- PDS Biotech Announces Presentation of Data from NCI-Led Triple Combination Phase 2 Clinical Trial in Advanced, Refractory HPV-Positive Cancers at ASCO 2022
- CIPN Market: 5.4% CAGR for Chemotherapy-Induced Peripheral Neuropathy Market Worth $1.17 Billion, Globally, by 2028: The Insight Partners
- PURA Enters Strategic Discussions To Bolster Industrial Hemp Strategy
- BioSig Advances its PURE™ System Commercial Launch to Medical Centers Nationwide
- Europe’s Leading Psychedelic Conference Returns to Amsterdam
- Baanbrekende Europese psychedelische conferentie vindt weer plaats in Amsterdam
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Delivery Tech Space
